Amarin Building

A History of Bold Action

About Amarin
Company History

Forging our future on the foundation of a BOLD past  

Amarin is built on a history of bold actions. Read below for highlights of our history as a company committed to being BOLD. 

Two Researchers Laptop

2008

Amarin Opens Research and Development Center

Amarin makes its entry into cardiovascular research and development and opens its R&D headquarters in Mystic, Connecticut.

Data Clipboard

2009

AMARIN RECEIVES SPA FOR PHASE 3 MARINE STUDY

Receives Special Protocol Assessment for its Phase 3 MARINE study evaluating AMR-101’s ability to lower triglycerides.

2011

2011

AMARIN COMMENCES 1ST PATIENT IN REDUCE-IT™ Trial

 

Commences first patient in REDUCE-IT, The Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial.”

+ LOAD MORE

our vision

Rethinking Cardiovascular Care.
Reducing Cardiovascular Risk.

LEARN MORE

Get to know Amarin

 

Who is Amarin? Amarin is a global pharmaceutical company that has developed and is pursuing additional treatments to help address cardiovascular disease. Amarin is relentless in its pursuit of scientific breakthroughs that can lead to revolutionary solutions that create a healthier world. Find out more about who we are, what we stand for and how we are making a difference in the lives of patients.

Where we are

 

Our Global Footprint

Amarin is making a positive impact on cardiovascular health across the world. Find out where we're located.

Earth Image

Contact Us

 


Amarin seeks to collaborate with others to address cardiovascular risk and create value.

Company Profile

A rapidly growing, international leader in the fight to address cardiovascular disease


Amarin focuses on a BOLD vision to stop cardiovascular disease from being a leading cause of death worldwide.

ALL-NP-00015 1/23